Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A crucial role for TGFbeta signaling in congenital eye disorders

14.12.2005


The lens in the developing eye acts as a TGFbeta signaling center that controls differentiation, survival and formation of multiple eye structures deriving from the neural crest. A study published today in the open access journal Journal of Biology shows that neural crest (NC) derived cells contribute to both anterior and posterior parts of the developing mammalian eye. NC cells migrate properly in the eye but fail to differentiate in the absence of TGFbeta signaling. The activity of TGFbeta is mediated by the two transcription factors Foxc1 and Pitx2 that have been implicated in human eye disorders. These findings shed light on the origin of congenital eye disorders that can give rise to glaucoma and blindness: Axenfeld-Rieger’s anomaly and persistent hyperplastic primary vitreous.



Lukas Sommer, from the Institute of Cell Biology at the ETH in Zurich, Switzerland, heading an international team including Lars Ittner, used in vivo cell fate mapping in mice. They show that NC-derived cells can be found in the eye vesicle of mouse embryos, soon after it is formed. NC-derived cells subsequently contribute to various structures of the developing eye, and Ittner et al. show for the first time an NC contribution to the primary vitreous.

TGFbeta receptor type 2, Tgfbr2, was inactivated to study the importance of the signaling pathway in NC-derived cells. In these mice, the eyes were reduced in size and the lens and cornea failed to separate. The authors show that TGFbeta signaling is crucial for proper differentiation and morphogenesis of NC-derived cells in eye structures. Conceivably, TGFbeta might be able to support differentiation not only during eye development but also at later stages. If so, this might open up new strategies for promoting regeneration of eye structures, for example in patients suffering from loss of corneal transparency.

Grace Baynes | EurekAlert!
Further information:
http://www.biomedcentral.com

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>